Similar articles for PMID: 25035260

Year	Number of Results
1990	2
1992	2
1994	4
1997	1
2001	2
2002	2
2003	3
2004	4
2005	2
2006	3
2007	3
2008	2
2009	6
2010	4
2011	8
2012	2
2013	4
2014	10
2015	8
2016	4
2017	5
2018	6
2019	8
2020	10
2021	5
2022	1

1

Advantages of single-use technology for vaccine fill-finish operations.

Jenness E, Walker S. Jenness E, et al. PDA J Pharm Sci Technol. 2014 Jul-Aug;68(4):381-3. doi: 10.5731/pdajpst.2014.00985. PDA J Pharm Sci Technol. 2014. PMID: 25035260

2

Option-based guarantees to accelerate urgent, high-risk vaccines: a new market-shaping approach.

Manheim D, Foster D. Manheim D, et al. F1000Res. 2020 Sep 18;9:1154. doi: 10.12688/f1000research.26482.2. eCollection 2020. F1000Res. 2020. PMID: 33500777 Free PMC article. Review.

3

Vaccine manufacturing: challenges and solutions.

Ulmer JB, Valley U, Rappuoli R. Ulmer JB, et al. Nat Biotechnol. 2006 Nov;24(11):1377-83. doi: 10.1038/nbt1261. Nat Biotechnol. 2006. PMID: 17093488

4

United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.

Perdue ML, Bright RA. Perdue ML, et al. Vaccine. 2011 Jul 1;29 Suppl 1:A48-50. doi: 10.1016/j.vaccine.2011.02.080. Vaccine. 2011. PMID: 21684430 Free article. Review.

5

Public vaccine manufacturing capacity in the Latin American and Caribbean region: current status and perspectives.

Cortes Mde L, Cardoso D, Fitzgerald J, DiFabio JL. Cortes Mde L, et al. Biologicals. 2012 Jan;40(1):3-14. doi: 10.1016/j.biologicals.2011.09.013. Epub 2011 Oct 26. Biologicals. 2012. PMID: 22033155 Review.

6

Analytics for vaccine economics and pricing: insights and observations.

Robbins MJ, Jacobson SH. Robbins MJ, et al. Expert Rev Vaccines. 2015 Apr;14(4):605-16. doi: 10.1586/14760584.2015.985662. Epub 2014 Dec 1. Expert Rev Vaccines. 2015. PMID: 25435003 Review.

7

Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States.

Shen AK, Rodewald LE, Birkhead GS. Shen AK, et al. Pediatrics. 2009 Dec;124 Suppl 5:S540-7. doi: 10.1542/peds.2009-1542N. Pediatrics. 2009. PMID: 19948586

8

Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.

[No authors listed] [No authors listed] Drugs R D. 2003;4(5):312-9. doi: 10.2165/00126839-200304050-00007. Drugs R D. 2003. PMID: 12952502 Review.

9

[Early achievements of the Danish pharmaceutical industry--8. Lundbeck].

Grevsen JV, Kirkegaard H, Kruse E, Kruse PR. Grevsen JV, et al. Theriaca. 2016;(43):9-61. Theriaca. 2016. PMID: 27491172 Danish.

10

Impact of BRICS' investment in vaccine development on the global vaccine market.

Kaddar M, Milstien J, Schmitt S. Kaddar M, et al. Bull World Health Organ. 2014 Jun 1;92(6):436-46. doi: 10.2471/BLT.13.133298. Bull World Health Organ. 2014. PMID: 24940018 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed